Skip to content

Adjunct 0.025% Povidone-Iodine Irrigation at Time of Vitrectomy for Management of Infectious Endophthalmitis: A Multicenter Single-Intervention Study.

Aug 2026 · Retina · 0 citations
Medicine

Abstract

Purpose

To determine whether adjunctive 0.025% povidone-iodine irrigation during pars plana vitrectomy might improve ocular morbidity in infectious endophthalmitis compared to standard irrigation.

Methods

Multicenter, retrospective, comparative cohort study (2019-2024) at four tertiary referral centers. 63 eyes from 63 patients with presumed infectious endophthalmitis requiring vitrectomy were included. Povidone-iodine group (n=32) received 0.025% povidone-iodine in balanced salt solution; control group (n=31) received standard irrigation. Primary outcome was visual acuity at 3 and 6 months. Secondary outcomes included reoperation rates and adverse events.

Results

Groups were similar in age, presenting visual acuity (20/2890 vs 20/4000), and culture positivity (13/32 [40.6%] vs 13/31 [41.9%]). Povidone-iodine group was associated with better median visual acuity at 3 months (20/138 [0.84 logMAR] vs 20/3000 [2.21 logMAR], P=.017) and 6 months (20/60 [0.48 logMAR] vs 20/400 [1.34 logMAR], p=.010). Vision improved in 96.7% (29/30) vs 48.3% (14/29) at 6 months (p<0.001). Clinically meaningful improvement of at least 0.3 logMAR occurred in 80.0% of PI-treated eyes (24/30) and 41.4% of control eyes (12/29; p=.003). Reoperation rates were statistically similar, but slightly increased in the povidone-iodine group (28.1% vs 16.1%, p=.365). No ocular toxicity was attributed to povidone-iodine.

Conclusion

Adjunctive 0.025% povidone-iodine irrigation during vitrectomy was associated with significantly improved visual outcomes without observed ocular toxicity. This simple, cost-effective intervention may benefit endophthalmitis management, though etiologic imbalances between groups limit attribution of this benefit to PI irrigation alone.

View source

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.